Work

A phase I/II study of TRC105 in combination with sorafenib in hepatocellular carcinoma (HCC).

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.3_suppl.291

Authors: Austin G. Duffy, Chi Ma, Susanna Varkey Ulahannan, Oxana V. Makarova-Rusher, Suzanne Fioravanti, Melissa Walker, Aradhana Venkatesan, Ismail B. Turkbey, Peter L. Choyke, Jane B. Trepel, Liang Cao, Kathryn Compton, William Douglas Figg, Tim F. Greten

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2562210181

Cites:

Cited by:

Related to: 10